Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biologic Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT07715045
What this trial is testing

Umbilical Cord Mesenchymal Stromal Cell Secretome for Moderate Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Universitas Sriwijaya 40
Early research (Phase 1)Ended earlyNCT04244552
What this trial is testing

A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies

Who this might be right for
Breast CancerColorectal CancerOvarian Cancer+13 more
Atreca, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Study completedNCT00637026
What this trial is testing

Ph II Early BC Pre-Surgical Biologic Study

Who this might be right for
Breast Cancer
AstraZeneca 65
Testing effectiveness (Phase 2)Study completedNCT06897748
What this trial is testing

Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated Eosinophils

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 98
Not applicableStudy completedNCT03670667
What this trial is testing

Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 1,132
Large-scale testing (Phase 3)Looking for participantsNCT06332534
What this trial is testing

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 110
Not applicableStudy completedNCT01936493
What this trial is testing

Biologic Predictors of Leiomyoma Treatment Outcomes

Who this might be right for
Uterine LeiomyomasFibroidsUterine Fibroids+1 more
Elizabeth A. Stewart 38
Not applicableWithdrawnNCT03511547
What this trial is testing

Comparison of Arthroscopic Supraspinatus Tendon Tear Repair in Patients Over 60 Years With and Without Patch Augmentation.

Who this might be right for
Rotator Cuff Tears
Schulthess Klinik
Not applicableEnded earlyNCT01794338
What this trial is testing

The Use of Biologic Mesh vs Bioabsorbable Mesh During Ventral Hernia Repair in At-risk Patients

Who this might be right for
Ventral Hernia
Wake Forest University Health Sciences 28
Large-scale testing (Phase 3)Study completedNCT00299546
What this trial is testing

The Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)

Who this might be right for
Arthritis, Rheumatoid
Centocor, Inc. 461
Not applicableStudy completedNCT01060046
What this trial is testing

Analysis and Characterization of Biologic Implants

Who this might be right for
Ventral HerniaPost-mastectomy Breast Reconstruction
Washington University School of Medicine 241
Not applicableStudy completedNCT01945580
What this trial is testing

Xenform Postmarket Surveillance Study

Who this might be right for
Pelvic Organ Prolapse
Boston Scientific Corporation 374
Early research (Phase 1)Study completedNCT02771340
What this trial is testing

Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma

Who this might be right for
Uveal MelanomaChoroid Neoplasm
Iconic Therapeutics, Inc. 10
Not applicableStudy completedNCT00978510
What this trial is testing

Study of Health Personnel and the Assistance to Patients With Tuberculosis in Hospital Environment

Who this might be right for
TuberculosisHealth Care ProfessionalsHospital Environment
Sociedade Cearense de Infectologia 159
Not applicableLooking for participantsNCT07411729
What this trial is testing

Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions

Who this might be right for
Emerging Infectious DiseasesCommunicable DiseasesBiological Warfare Agents+2 more
Assistance Publique - Hôpitaux de Paris 800
Early research (Phase 1)Study completedNCT06363383
What this trial is testing

Evaluate the Safety of an Oral Biologic in Healthy Participants

Who this might be right for
Ulcerative Colitis
Mage Biologics 48
Large-scale testing (Phase 3)Study completedNCT02499783
What this trial is testing

Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 205
Large-scale testing (Phase 3)UnknownNCT05616754
What this trial is testing

A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 400
Not applicableStudy completedNCT02582320
What this trial is testing

Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program

Who this might be right for
Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 264
Next Page